The CNS is made up of these 2 areas of the body

Once a neuron reaches a certain voltage, called a ______________, the cell will fire an action potential.

Name the 3 types of small molecule neurotransmitters.

Approximately ________ million children and adolescents in the US have been diagnosed with ADHD, or _________ percent?

This is the duration of treatment effect of Mydayis in adolescents, as determined by Study 202.

This is closely linked to emotional behaviors and disorders, particularly involuntary motor and visceral reactions.

Neurons have a _____________________ resting potential.

Name the 5 biogenic amines.

Approximately ________ million adults in the US have been diagnosed with ADHD, or _________ percent?

This is the duration of treatment effect of Mydayis 50mg in adults, as determined by Study 201.

ADHD is a neurobiologic disorder thought to be associated with alterations in this area of the brain.

These are released when an action potential reaches the presynaptic terminal. They then cross the synapse to bind to receptors on the post-synaptic neuron.

This is the major excitatory neurotransmitter in the CNS; this is the major inhibitory neurotransmitter.

Childhood ADHD persists into adulthood what percent of the time?

What was the primary efficacy measure for all double-blind Phase 3 Mydayis trials?

These are the most important parts of the diencephalon.

This is the space between pre- and post-synaptic neurons and is specialized for release and reception of chemical transmitters.

The majority of norepinephrine is located here in the brain.

Heritability of ADHD is estimated at...

This trial supports the use of Mydayis 12.5mg and 37.5mg once daily in the treatment of adult ADHD.

The prefrontal cortex performs these 4 executive functions.

Neurotransmitters are cleared from the synapse these 3 ways.

_________________ levels of DA and NE activity provide optimal prefrontal functioning.

The MTA study showed __________% of children have ADHD alone.

This was the starting dose for all adolescents in dose-optimization Study 305.